During the past decade, Kentuckiana Pulmonary Research Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kentuckiana Pulmonary Research Center" #1 sponsor was "United Therapeutics" with 2 trials, followed by "Actelion" with 1 trials sponsored, "Altavant Sciences GmbH" with 1 trials sponsored, "GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc." with 1 trials sponsored and "Jazz Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kentuckiana Pulmonary Research Center" #1 collaborator was "Altavant Sciences, Inc." with 1 trials as a collaborator, "Nuventra, Inc." with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kentuckiana Pulmonary Research Center" are "Pulmonary Arterial Hypertension" (4 trials), "Cardiovascular Diseases" (2 trials), "Connective Tissue Diseases" (2 trials), "Familial Primary Pulmonary Hypertension" (2 trials) and "Hypertension" (2 trials). Many other conditions were trialed in "Kentuckiana Pulmonary Research Center" in a lesser frequency.

Most popular intervention types in "Kentuckiana Pulmonary Research Center" are "Drug" (8 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ralinepag" (2 trials), "GB002 (seralutinib)" (1 trials), "Generic Dry Powder Inhaler" (1 trials) and "LIQ861 Inhaled Treprostinil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kentuckiana Pulmonary Research Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Kentuckiana Pulmonary Research Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Kentuckiana Pulmonary Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kentuckiana Pulmonary Research Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".